Latest News about MRK
Recent news which mentions MRK
Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients
December 13, 2024
From Benzinga
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
December 12, 2024
From Motley Fool
AstraZeneca-Merck Partnered Lynparza Shows Long-Term Survival With Reduced Death Risk Of 28% In Breast Cancer Patients
December 11, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 10, 2024
From Benzinga
Merck Reveals Mixed Data From Keytruda/Lynparza Regime In Ovarian Cancer
December 09, 2024
From Benzinga
2 Healthcare Dividend Stocks to Hold for the Long Haul
December 07, 2024
From Motley Fool
Why Summit Therapeutics Stock Rocketed 6% Higher on Friday
December 06, 2024
From Motley Fool
This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy?
December 05, 2024
From Motley Fool
3 Ultra-Cheap Dividend Stocks to Buy in December
December 05, 2024
From Motley Fool
From Benzinga
The Smartest Dividend Stocks to Buy With $3,000 Right Now
November 28, 2024
From Motley Fool
Why Is Merck Stock Trading Higher On Monday?
November 25, 2024
From Benzinga
Pyxis Oncology's Cancer Drug Progress Stirs Analyst Concerns
November 21, 2024
From Benzinga
2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist
November 21, 2024
From Motley Fool
Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
November 19, 2024
From Benzinga
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
November 15, 2024
From Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
November 15, 2024
From Benzinga
Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial
November 14, 2024
From Benzinga
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
November 13, 2024
From Benzinga
3 Stocks Poised for a Breakout
November 09, 2024
From Motley Fool
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
November 08, 2024
From Benzinga
2 Hot Biopharma Stocks to Buy and Hold for 5 Years
November 08, 2024
From Motley Fool
Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows.
November 07, 2024
From Motley Fool
Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
November 07, 2024
From Benzinga
Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom
November 06, 2024
From Benzinga
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
November 05, 2024
From Motley Fool
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
November 04, 2024
From Benzinga
Is Pfizer Stock a Bargain for Long-Term Investors?
November 04, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.